My Best Ideas 24 September 2017 This is a list of companies that have a very nice estimated one year return on invested capital based on the sum of the delta of the one year estimated price target plus the calculated one year dividend yield. (Full List)
Dividend Increases 25 - 29 September 2017 This is a list of those companies that have recently increased their dividends. The list includes the amount and percentage of the increase, the forward dividend yield, and the ExDividend, Record and Payment dates. (Full List)
The Markets Keep Rising 24 September 2017 The strength of the markets is incredible. Despite the FED re-emphasizing the idea that a rate hike is almost certain later this year and RocketMan once again threatening to annihilate the US, the DJIA average again moved higher last week. It really feels like nothing will slow this market down. And that idea is raising the antenna of those contrarian investors. Just Apple alone can push the markets higher or lower on any given day and recently it hasn't been performing very well. I remain fully invested in this market but I'm becoming more selective in what I'm buying.
Improving on Livermore
Jesse Livermore once gave this important piece of advice to investors --
“It was never my thinking that made the big money for me, it was always the sitting.”
I think I've improved on that advice.
A Quick Look at Kindred BioSciences 28 September 2017 When one of Kindred BioScience's founders was the Chief Executive Officer of OneWorld Health, he noticed something extraordinary. Richard was developing drugs to fight diseases like malaria and cholera. As he searched high and low for new drugs, he realized that drugs for neglected diseases often come from the veterinary field. (Full Article)
Interface Inc Revisited 26 September 2017 Interface is the future of carpeting for both home and office. It's the largest manufacturer of modular carpet that needs minimal installation and can be done literally by anyone. By installing it as squares or planks, the carpet can be easily removed or replaced in a single afternoon. The company was founded in 1973, and is based in Atlanta, Georgia. (Full Article)
Micron Technology 21 September 2017 DRAM producers are notoriously famous for being cyclical. Micron Technology is no different. So for me this could never be a long term investment. The way I'm approaching it is through swing trading. Projections have this stock going to $43 within the year and I think that's very possible. But being a cyclical stock, I'll be watching this closely. (Full Article)
Manipulating the Genome 19 September 2017 As most will agree, the search for the medical cures of tomorrow will ultimately be found inside the Human Genome. And those cures will be treated by editing the gene sequences to eliminate the defective sequences. We're only now scratching the surface of this relatively new technology and there'll be both corporate winners and losers..... (Full Article)
Investment Risk vs Inflation 14 September 2017 I wish I could invest without risk. I wish I could get a guaranteed return on my investment. I wish there was no such thing as inflation. But wishing for things is simply the desire for things that I have no other way of getting. Risk is everywhere and inflation has been around longer than I’ve been alive. Unfortunately both are here to stay. (Full Article)
News is a Lagging Indicator 12 September 2017 For the most part, there’s always a lag in the news. It’s not as bad as it use to be but it’s still there. The news media are always reporting something that’s already happened. Sometimes days ago, sometimes only a few hours ago, but for the most part the event is already over and professional traders have already placed their trades. (Full Article)
Pragmatism in Investing 11 September 2017 Stocks don’t go up or down forever. They go up as long as investors push them up and they go down as long as investors push them down. In each case they will eventually reverse and head in the opposite direction. They do this for many reasons like product cycles, earnings surprises, buying seasons, management changes, fed policy, wars and more. (Full Article)
Edwards Lifesciences 8 September 2017 Edwards Lifesciences is the global leader in patient-focused innovations for structural heart disease and critical care monitoring. A pioneer in the development of heart valve therapies, the Company is the world’s leading manufacturer of heart valve systems and repair products used to replace or repair a patient’s diseased or defective heart valve. (Full Article)
Edwards Weekly Chart
Abeona Therapeutics 7 September 2017 Abeona, a biopharmaceutical company, focuses on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. The company offers MuGard, a mucoadhesive oral wound rinse for mucositis, stomatitis, aphthous ulcers, and traumatic ulcers; and ProctiGard, a mucoadhesive oral wound rinse.... (Full Article)
Abeona Weekly Chart
ImmunoGen Inc 6 September 2017 ImmunoGen, a clinical-stage biotechnology company, develops targeted anticancer therapeutics. The company develops its products using its antibody-drug conjugate technology. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha for the treatment of platinum-resistant.... (Full Article)
ImmuneGen Weekly Chart
Corcept Therapeutics 5 September 2017 Corcept, a pharmaceutical company, discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. It offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with.... (Full Article)
Corcept Weekly Chart
Systemax 31 August 2017 Systemax operates as a direct marketer of brand name and private label products. Its Industrial Products Group segment sells a range of maintenance, repair, and operation products. The company's EMEA Technology Products Group segment sells information and communication technology products. (Full Article)
Sangamo Therapeutics 29 August 2017 I got interested in Sangamo Therapeutics primarily because of its stock chart. This company has been in an uptrend since the beginning of the year and in May it got supercharged. Since then its continued higher and today is in a confirmed uptrend. Today sales have been more than doubling as earnings have been increasing at a rate greater than 50%. (Full Article)
NovoCure 24 August 2017 NovoCure has been consolidating since the beginning of July as the 50 dma continued to rise. At this point the stock price is now bouncing off that moving average and ready to move higher. A move above $22 per share would signal a now leg higher. Wait for it.
NovoCure Daily Chart
Calavo Growers 22 August 2017 California Avocados are finally being discovered outside California and Calavo is perfectly situated to take advantage of that trend. It's also going to help the price trend of the stock. I've had a small number of shares of this company for the last several years with dividend reinvestment and I've been quite happy owning these shares. (Full Article)
Acadia Pharmaceuticals 17 August 2017 ACADIA Pharmaceuticals is focused on the development and commercialization of innovative medicines to address unmet medical needs in neurological and related central nervous system disorders. Their efforts are focused in Parkinson’s disease psychosis, for which they have the first and only treatment approved by the FDA, as well as clinical... (Full Article)
Vericel Corporation 16 August 2017 Vehicle Corp is a commercial stage company with three marketed drugs. The company's research focus is on cell based therapies. In the spring of 2013 Vericel acquired from Sanofi their "cell therapy and regenerative medicine business" which it had received when it purchased Genzyme in 2011. (Full Article)
Advanced Energy Industries 15 August 2017 Advanced Energy Industries is an American company that develops power and control technologies for the manufacture of flat panel displays, semiconductors, data storage products, solar cells and architectural glass. Founded in 1981, AE operates in regional centers in North America, Asia, and Europe. (Full Article)
Corindus Vascular Robotics 10 August 2017 Corindus Vascular Robotics is in the robotic-assisted precision vascular intervention systems industry. They design, manufacture, and sell robotic systems for use in interventional vascular procedures. Corindus came to my attention during one of my screens because of its change in trend earlier this year. This signaled for me a significant and sustainable move higher. My conclusion is to start a small position and see where it goes. (Full Article)
HealthEquity 8 August 2017 Health Savings Accounts may just be the solution to this country's current healthcare crisis and HealthEquity Inc may just be the company with that solution. HealthEquity Inc is a non-bank health savings trustee which allows HealthEquity to be the custodian of health savings accounts regardless of which financial institution the funds are deposited with. (Full Article)
Vertex Pharmaceuticals 3 August 2017 Vertex is an American pharmaceutical company founded in 1989 and located in Boston, Massachusetts. The Company was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. Its product pipeline focused on viral infections, inflammatory and autoimmune disorders, and cancer. (Full Articles)
BioSpecifics Technologies 25 July 2017 BioSpecifics is a biopharmaceutical company that has developed injectable collagenase for 12 clinical indications to date. Injectable collagenase is marketed as XIAFLEX® in the U.S. for the treatment of Dupuytren's contracture and Peyronie's disease by BioSpecifics' partner, Endo. XIAFLEX® is also commercialized in Japan, Europe, Canada and Australia for Dupuytren’s contracture and also for Peyronie's disease in Europe and Australia. (Full Article)
Visa and MasterCard 23 July 2017 No explanation is needed to understand a debit and credit card company. We all carry them with us wherever we go. They are now integral to the modern lifestyle. And everyone knows that they're making tons of money. Just look at your recent credit card statement. But they're not cheap. They never were. But at the end of the day Visa and MasterCard have made a lot of money for their shareholders.
An Update on RICK's 14 July 2017 RCI Hospitality has been beefing up it's collection of Gentlemen's Clubs while at the same time continuing to develop its entry into the Casual Dining segment of the restaurant business. And so far its starting to gain traction as plans to expand move forward. But this is a transition period that's setting the groundwork for increasing revenues, earnings and dividends.(Full Article)
Take-Two Interactive 6 July 2017 Take-Two Interactive is a creator and distributor of video games and peripherals and owns Rockstar Games and 2K Games. Notable game series include Grand Theft Auto, Civilization, NBA 2K, BioShock and Borderlands. As owner of 2K Games, Take-Two publishes its 2K Sports titles, and creates free-to-play mobile titles through Social Point. (Full Article)
Weight Watchers 3 July 2017 There's no doubt that the world is getting bigger. Luckily Weight Watchers has been assisting individuals in their attempt to loose weight for quite a few years. Now the stock has started to get traction, has moved above resistance and has started to move higher. That may be the result of a turnaround currently going on as the fundamentals have significantly improved lately. (Full Article)
Novocure 20 June 2017 Novocure may have finally found a bottom earlier this year. The stock has doubled since April and it's starting to look like there's a lot more room to go even higher. The Company has developed a 4th method of treating cancers that can augment or replace surgery, radiation therapy and chemotherapy. (Full Article)
Immunomedics 13 June 2017 This Company caught my attention after just one look at the P&F chart. For 7 years there's been resistance near $7 per share as the stock was turned back three times before breaking through. It's now pushed above $8 per share. I believe shares of this company will find support near $7 per share if there's any pullback in the shares and they'll rise to near $12 per share over the next year as earnings turn positive. (Full Article)
Always Have an Exit Strategy The exit strategy is always a mandatory precondition for any trade I enter. All other strategies will have disaster embedded at their core. All other strategies are simply an emotional reaction to events external to the markets. All other strategies will accentuate a reward while ignoring the damage that's incurred by accepting such an extensive implied risk. These are the strategies that I personally refuse to implement into my trading strategy. (Full Article)
The Spoils of Investing Sometimes it's good to take money out of the market and enjoy the spoils of investing. Not everything needs to be continually reinvested back into the markets. Three years ago I decided to spoil my son. So I got him this Nissan 370Z. It's been a great car. He's been a great kid!
Interested in reading more articles like the ones above? I've been writing articles for over three years and many of my best ideas can be found in those articles. Click the button below or use the drop down menu above labeled "INDEX". Reflection is often the first step in finding success in the markets.
Investors and Traders Read These Articles As Many As 200,000 Times Each Month.
In 2016 the DJIA ended at 19,762
In 2015 the DJIA ended at 17,425
In 2014 the DJIA ended at 17,823
In 2013 the DJIA ended at 16,576
One Percent per Month
My Investing Strategy I like to keep things simple when I invest because I'm a pretty simple guy. And I don't think there's a simpler or an easier way to invest than "Buy, Write, Collect". Here's the three steps in their entirety. 1. Buy the Stock, 2. Write the Option, and 3. Collect the Dividend. (Full Article)
A Basic Options Strategy If you’ve ever considered an options strategy as part of your overall investment strategy, here’s a relatively simple trade that I often execute to supplement my dividend income. (Full Article)
Reviewing Those Dividend Increases I've listed companies increasing their dividend in the Dividend Increases part of this site because I've found this to be a fertile area for finding candidates for consideration. Companies that pay an annual dividend of at least 2% and increase that dividend at a rate greater than inflation for a number of years are the kind of companies that every DGI is attracted to. And if that company has a one year estimated capital gain of 10% or more, I start to buy shares in that company.
Buying Great Companies I've posted a lot of great companies that have raised their dividend pretty consistently over the years and that's the key to becoming a successful investor. It's really not as hard as most people think. Study those companies that raise their revenues, earnings and dividends over an extended period of time. Read their history. And learn what makes a great investment.
DISCLAIMER I am not a licensed investment adviser, and I am not providing investment advice for you on this site. Please consult with an investment professional before you invest your money. Any opinion expressed here should not be treated as investment advice. I am not liable for any losses suffered by any party because of data or information published on this blog. Past performance is not a guarantee of future performance. Unless your investments are FDIC insured, they may decline in value.